Alivus Life Sciences Ltd has temporarily suspended production at its Dahej, Gujarat API plant following a fire incident. The blaze, controlled within an hour, resulted in three injuries. The company is investigating the cause and assessing damage while ensuring safety measures and continuity planning remain a top priority.
Key Highlights & Developments
Alivus Life Sciences Ltd has announced a temporary suspension of production at its Active Pharmaceutical Ingredient (API) plant in Dahej, Gujarat after a fire broke out on-site.
-
Incident Overview: The fire was reported at the Dahej facility and was brought under control within one hour, minimizing further risk.
-
Casualties: Three individuals sustained injuries during the incident. The company has confirmed that medical assistance was provided promptly.
-
Operational Impact: Production at the plant has been temporarily halted as safety checks and damage assessments are carried out.
-
Investigation: Alivus Life Sciences has initiated a thorough investigation to determine the cause of the fire and to evaluate the extent of damage to infrastructure and equipment.
-
Safety Measures: The company emphasized its commitment to employee safety and regulatory compliance, noting that emergency protocols were activated swiftly to contain the situation.
Strategic Outlook
While the immediate focus remains on recovery and safety, the company is expected to reassess operational timelines and continuity plans once the investigation concludes. The incident underscores the importance of robust safety frameworks in pharmaceutical manufacturing, especially in high-risk API production environments.
Sources: Alivus Life Sciences Ltd corporate announcement; Business Standard pharma industry coverage; Economic Times market updates